Author:
Choi Jung-Hyun,Zhang Xu,Zhang Christine,Dai David L.,Luo Jun,Ladak Reese,Li Qian,Wiebe Shane,Liu Alex C.H.,Ran Xiaozhuo,Yang Jiaqi,Naeli Parisa,Garzia Aitor,Zhou Lele,Mahmood Niaz,Deng Qiyun,Elaish Mohamed,Lin Rongtuan,Hobman Tom,Pelletier Jerry,Alain Tommy,Vidal Silvia,Duchaine Thomas,Mazhab-Jafari Mohammad T.,Mao Xiaojuan,Jafarnejad Seyed Mehdi,Sonenberg Nahum
Abstract
AbstractViruses evade the innate immune response by suppressing the production or activity of cytokines such as type I interferons (IFNs). Here we report the discovery of a novel mechanism by which the SARS-CoV-2 virus co-opts an intrinsic cellular machinery to suppress the production of the key immunostimulatory cytokine IFN-β. We reveal that the SARS-CoV-2 encoded Non-Structural Protein 2 (NSP2) directly interacts with the cellular GIGYF2 protein. This interaction enhances the binding of GIGYF2 to the mRNA cap-binding protein 4EHP, thereby repressing the translation of the Ifnb1 mRNA. Depletion of GIGYF2 or 4EHP significantly enhances IFN-β production, leading to reduced viral infection. Our findings reveal a new target for rescuing the antiviral innate immune response to SARS-CoV-2 and other RNA viruses.
Publisher
Cold Spring Harbor Laboratory
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献